A Clinical Trial Coordinator plays a central role in the planning and execution of clinical research studies by ensuring that each trial runs smoothly, ethically, and in compliance with regulatory requirements. Their responsibilities include coordinating trial logistics, managing participant schedules, maintaining accurate study documentation, and supporting data collection processes. They act as a point of contact between sponsors, investigators, regulatory bodies, and clinical site staff to ensure consistent communication and timely progress throughout the trial.
In addition to administrative and regulatory duties, Clinical Trial Coordinators are actively involved in participant care, from screening and enrollment to follow-up. They are responsible for ensuring that informed consent is obtained and that study participants are treated according to the trial protocol. They help prepare for site audits and inspections, assist with adverse event reporting, and support data integrity efforts by ensuring timely and accurate data entry. Their in-depth understanding of clinical research guidelines, such as Good Clinical Practice (GCP), allows them to maintain compliance and high ethical standards throughout the trial. They must also manage multiple priorities under tight deadlines and adapt quickly to evolving study needs. Their contribution ensures trials not only meet scientific objectives but also protect participant safety and trust. By balancing clinical, regulatory, and operational tasks, they ensure that each study contributes valid and valuable results to medical research.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia